Zacks Research Has Negative Outlook of Avantor Q3 Earnings

Avantor, Inc. (NYSE:AVTR) – Stock analysts at Zacks Research lowered their Q3 2026 earnings per share estimates for Avantor in a research note issued to investors on Tuesday, March 25th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.27 per share for the quarter, down from their previous forecast of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s FY2026 earnings at $1.13 EPS and FY2027 earnings at $1.33 EPS.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the prior year, the firm posted $0.22 EPS.

Other analysts have also recently issued reports about the company. Raymond James reissued an “outperform” rating and issued a $24.00 price target (down from $26.00) on shares of Avantor in a research report on Monday, February 10th. UBS Group reissued a “neutral” rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Barclays lowered their price target on Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Citigroup dropped their price target on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, Morgan Stanley reduced their price objective on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $25.50.

Avantor Trading Down 0.5 %

NYSE:AVTR opened at $16.28 on Thursday. The firm has a market capitalization of $11.08 billion, a P/E ratio of 15.65, a PEG ratio of 1.55 and a beta of 1.30. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor has a one year low of $15.37 and a one year high of $28.00. The company’s 50-day simple moving average is $18.65 and its 200 day simple moving average is $21.53.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB raised its holdings in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC increased its position in Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after buying an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its stake in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after buying an additional 1,067 shares during the period. UMB Bank n.a. lifted its position in shares of Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC purchased a new position in shares of Avantor during the 4th quarter valued at about $65,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling

In other news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.